{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T08:36:34Z","timestamp":1762331794298,"version":"build-2065373602"},"reference-count":25,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T00:00:00Z","timestamp":1738627200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Formosan Medical Association"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.jfma.2025.02.003","type":"journal-article","created":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T23:33:46Z","timestamp":1739230426000},"page":"938-943","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Fewer good-quality cleavage embryos in dydrogesterone-primed ovarian stimulation compared to GnRH antagonist protocol in POSEIDON group 4 patients"],"prefix":"10.1016","volume":"124","author":[{"given":"Nguyen Thi Lien","family":"Huong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bui Thi","family":"Hanh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nguyen Thi Bich","family":"Van","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9082-2437","authenticated-orcid":false,"given":"Phi Thi Tu","family":"Anh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2829-3875","authenticated-orcid":false,"given":"Hoang Bao","family":"Long","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3703-3810","authenticated-orcid":false,"given":"Le Duc","family":"Thang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tran Thu","family":"Thuy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nguyen Thi","family":"Minh Thu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dang Tuan","family":"Anh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4756-9037","authenticated-orcid":false,"given":"Phan Ngoc","family":"Quy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2190-3087","authenticated-orcid":false,"given":"Le Quang","family":"Do","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Than Trong","family":"Thach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean Noel","family":"Hugues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4022-0051","authenticated-orcid":false,"given":"Do Van","family":"Tien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2192-572X","authenticated-orcid":false,"given":"Le","family":"Hoang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jfma.2025.02.003_bib1","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/j.fertnstert.2016.02.005","article-title":"A new more detailed stratification of low responders to ovarian stimulation: from a poor ovarian response to a low prognosis concept","volume":"105","author":"Alviggi","year":"2016","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.jfma.2025.02.003_bib2","doi-asserted-by":"crossref","first-page":"24","DOI":"10.23736\/S0031-0808.18.03511-5","article-title":"Novel approaches for diagnosis and management of low prognosis patients in assisted reproductive technology: the POSEIDON concept","volume":"61","author":"Conforti","year":"2019","journal-title":"Panminerva Med"},{"issue":"2","key":"10.1016\/j.jfma.2025.02.003_bib3","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.rbmo.2019.03.212","article-title":"Use of progestins to inhibit spontaneous ovulation during ovarian stimulation: the beginning of a new era?","volume":"39","author":"La Marca","year":"2019","journal-title":"Reprod Biomed Online"},{"issue":"2","key":"10.1016\/j.jfma.2025.02.003_bib4","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jogoh.2018.10.008","article-title":"Progestin-primed ovarian stimulation is a feasible method for poor ovarian responders undergoing in IVF\/ICSI compared to a GnRH antagonist protocol: a retrospective study","volume":"48","author":"Huang","year":"2019","journal-title":"J. Gynecol. Obstet. Hum. Reprod."},{"issue":"1","key":"10.1016\/j.jfma.2025.02.003_bib5","article-title":"Comparison of the pregnancy outcomes of progestin-primed vs. antagonist ovarian stimulation in patients with poor ovarian response: a retrospective study","volume":"40","author":"Shi","year":"2024","journal-title":"Gynecol Endocrinol Off J Int Soc Gynecol Endocrinol"},{"key":"10.1016\/j.jfma.2025.02.003_bib6","article-title":"The clinical value of progestin-primed ovarian stimulation protocol for women with diminished ovarian reserve undergoing IVF\/ICSI: a systematic review and meta-analysis","volume":"14","author":"Lin","year":"2023","journal-title":"Front Endocrinol"},{"issue":"2","key":"10.1016\/j.jfma.2025.02.003_bib7","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/humrep\/dex367","article-title":"New application of dydrogesterone as a part of a progestin-primed ovarian stimulation protocol for IVF: a randomized controlled trial including 516 first IVF\/ICSI cycles","volume":"33","author":"Yu","year":"2018","journal-title":"Hum Reprod"},{"issue":"4","key":"10.1016\/j.jfma.2025.02.003_bib8","doi-asserted-by":"crossref","first-page":"293","DOI":"10.4274\/jtgga.galenos.2020.2020.0110","article-title":"The efficacy of dydrogesterone use to suppress premature luteinizing hormone surge on cycle outcomes in controlled ovarian stimulation","volume":"22","author":"Do\u011fan Durda\u011f","year":"2021","journal-title":"J Turk Ger Gynecol Assoc"},{"issue":"4","key":"10.1016\/j.jfma.2025.02.003_bib9","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.fertnstert.2018.01.003","article-title":"Recombinant luteinizing hormone supplementation in assisted reproductive technology: a systematic review","volume":"109","author":"Alviggi","year":"2018","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jfma.2025.02.003_bib10","doi-asserted-by":"crossref","DOI":"10.1093\/humrep\/deae108.1013","article-title":"P-683 Progestins vs flexible GnRH antagonist for LH suppression during controlled ovarian stimulation in POSEIDON groups 3 and 4 patients: analysis of effectiveness and cycle outcomes","volume":"39","author":"Parhar","year":"2024","journal-title":"Hum Reprod"},{"issue":"6","key":"10.1016\/j.jfma.2025.02.003_bib11","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1093\/humrep\/der037","article-title":"Alpha scientists in reproductive medicine and ESHRE special interest group of embryology, \u201cthe Istanbul consensus workshop on embryo assessment: proceedings of an expert meeting,\u201d","volume":"26","year":"2011","journal-title":"Hum Reprod Oxf Engl"},{"issue":"4","key":"10.1016\/j.jfma.2025.02.003_bib12","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/S0015-0282(99)00311-8","article-title":"Blastocyst culture and transfer: analysis of results and parameters affecting outcome in two in vitro fertilization programs","volume":"72","author":"Schoolcraft","year":"1999","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jfma.2025.02.003_bib13","article-title":"Comparison of cumulative live birth rates between GnRH-A and PPOS in low-prognosis patients according to POSEIDON criteria: a cohort study","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Endocrinol"},{"issue":"1","key":"10.1016\/j.jfma.2025.02.003_bib14","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12958-023-01124-3","article-title":"Progestin Primed Ovarian Stimulation (PPOS) protocol yields lower euploidy rate in older patients undergoing IVF","volume":"21","author":"Pai","year":"2023","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.jfma.2025.02.003_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.705264","article-title":"Comparison of the cumulative live birth rates of progestin-primed ovarian stimulation and flexible GnRH antagonist protocols in patients with low prognosis","volume":"12","author":"Du","year":"2021","journal-title":"Front Endocrinol"},{"issue":"1","key":"10.1016\/j.jfma.2025.02.003_bib16","article-title":"Comparison of the pregnancy outcomes of progestin-primed vs. antagonist ovarian stimulation in patients with poor ovarian response: a retrospective study","volume":"40","author":"Shi","year":"2024","journal-title":"Gynecol Endocrinol Off J Int Soc Gynecol Endocrinol"},{"issue":"3","key":"10.1016\/j.jfma.2025.02.003_bib17","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00404-018-4856-8","article-title":"New trial of progestin-primed ovarian stimulation using dydrogesterone versus a typical GnRH antagonist regimen in assisted reproductive technology","volume":"298","author":"Iwami","year":"2018","journal-title":"Arch Gynecol Obstet"},{"issue":"Aug","key":"10.1016\/j.jfma.2025.02.003_bib18","article-title":"Progestin-primed ovarian stimulation protocol for patients in assisted reproductive technology: a meta-analysis of randomized controlled trials","volume":"12","author":"Guan","year":"2021","journal-title":"Front Endocrinol"},{"issue":"1","key":"10.1016\/j.jfma.2025.02.003_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0145895","article-title":"Elevated progesterone levels on the day of oocyte maturation may affect top quality embryo IVF cycles","volume":"11","author":"Huang","year":"2016","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.jfma.2025.02.003_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0176482","article-title":"Top quality blastocyst formation rates in relation to progesterone levels on the day of oocyte maturation in GnRH antagonist IVF\/ICSI cycles","volume":"12","author":"Vanni","year":"2017","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.jfma.2025.02.003_bib21","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.3390\/jcm13123439","article-title":"Premature progesterone rise is associated with higher cumulative live birth rate with freeze-all strategy","volume":"13","author":"Wang","year":"2024","journal-title":"J Clin Med"},{"issue":"2","key":"10.1016\/j.jfma.2025.02.003_bib22","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00404-020-05792-z","article-title":"Being on the side of old findings: progesterone elevation on the day of oocyte maturation induction does not affect embryological parameters throughout the blastocyst culture period","volume":"303","author":"Turgut","year":"2021","journal-title":"Arch Gynecol Obstet"},{"issue":"Sep","key":"10.1016\/j.jfma.2025.02.003_bib23","article-title":"Comparison of dydrogesterone and medroxyprogesterone in the progestin-primed ovarian stimulation protocol for patients with poor ovarian response","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Endocrinol"},{"issue":"4","key":"10.1016\/j.jfma.2025.02.003_bib24","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.jfma.2023.12.008","article-title":"Non-inferiority of progestin-primed ovarian stimulation versus GnRH antagonist protocol: a propensity score-weighted analysis","volume":"123","author":"Duc Thang","year":"2024","journal-title":"J Formos Med Assoc Taiwan Yi Zhi"},{"issue":"5","key":"10.1016\/j.jfma.2025.02.003_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.rbmo.2023.103732","article-title":"Progestin primed ovarian stimulation using dydrogesterone from day 7 of the cycle onwards in oocyte donation cycles: a longitudinal study","volume":"48","author":"Hendrickx","year":"2024","journal-title":"Reprod Biomed Online"}],"container-title":["Journal of the Formosan Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664625000452?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664625000452?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T08:32:00Z","timestamp":1762331520000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929664625000452"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":25,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S0929664625000452"],"URL":"https:\/\/doi.org\/10.1016\/j.jfma.2025.02.003","relation":{},"ISSN":["0929-6646"],"issn-type":[{"type":"print","value":"0929-6646"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fewer good-quality cleavage embryos in dydrogesterone-primed ovarian stimulation compared to GnRH antagonist protocol in POSEIDON group 4 patients","name":"articletitle","label":"Article Title"},{"value":"Journal of the Formosan Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfma.2025.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2025, Formosan Medical Association. Published by Elsevier Taiwan LLC. All rights are reserved.","name":"copyright","label":"Copyright"}]}}